Carbidopa (Oceanside Pharmaceuticals)
Welcome to the PulseAid listing for the Carbidopa drug offered from Oceanside Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Oceanside Pharmaceuticals |
NON-PROPRIETARY NAME: | Carbidopa Tablets |
SUBSTANCE NAME: | CARBIDOPA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2014-04-04 |
END MARKETING DATE: | 0000-00-00 |
Carbidopa HUMAN PRESCRIPTION DRUG Details:
Item Description | Carbidopa from Oceanside Pharmaceuticals |
LABELER NAME: | Oceanside Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2014-04-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68682-200_32765836-72d3-4eb4-9f96-589f9518d3be |
PRODUCT NDC: | 68682-200 |
APPLICATION NUMBER: | NDA017830 |
Other CARBIDOPA Pharmaceutical Manufacturers / Labelers: